
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
FcRH1 CRISPR/Cas9 KO Plasmid (m) | sc-432859 | 20 µg | $397.00 |
Fcrl1 encodes Fc receptor-like 1 (FcRH1), a B cell–associated immunoregulatory receptor implicated in tuning antigen receptor–driven signaling and downstream activation programs. In mouse lymphoid tissues, FcRH1 expression is linked to B cell differentiation states and modulation of proximal signaling events that intersect with pathways controlling calcium flux, MAPK activity, and transcriptional responses following BCR engagement. By influencing thresholds for B cell activation and survival, Fcrl1 provides a functional entry point for studying germinal center dynamics, immune tolerance, and mechanisms that shape antibody responses. Dysregulated Fc receptor–like signaling networks are frequently examined in the context of aberrant B cell phenotypes and immune-associated pathologies, supporting the relevance of Fcrl1 for mechanistic immunology research.
FcRH1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Fcrl1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Fcrl1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Fcrl1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish FcRH1 protein expression.
This CRISPR knockout system enables efficient generation of Fcrl1-deficient cell models for investigation of FcRH1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.